Simmunext Biotherapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Simmunext Biotherapeutics General Information
Description
Developer of polymer-based immunofilament therapeutics designed to restore and enhance immune function in cancer and other diseases. The company leverages a proprietary nanotechnology platform by combining cutting-edge polymer chemistry, tumor immunology and industrial drug development expertise to mimics natural immune cell activity for the treatment of cancer, autoimmune disorders and infectious diseases, enabling healthcare institutions to improve clinical outcomes and broaden patient access to advanced immunotherapies.
Contact Information
Website
www.simmunext.comCorporate Office
- Geert Grooteplein Zuid 10
- Nijmegen
- Netherlands
Corporate Office
- Geert Grooteplein Zuid 10
- Nijmegen
- Netherlands
Simmunext Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 09-Aug-2023 | Completed | Startup | |||
| 1. Early Stage VC (Series 1) | 01-Jan-2022 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Simmunext Biotherapeutics Signals
Simmunext Biotherapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| VFF Gelderland | Corporation | Minority | ||
| Oncode Oncology Bridge Fund | Venture Capital | Minority | ||
| Radboud University | University | Minority | ||
| Radboud university medical center | Corporation | Minority |
Simmunext Biotherapeutics FAQs
-
When was Simmunext Biotherapeutics founded?
Simmunext Biotherapeutics was founded in 2022.
-
Where is Simmunext Biotherapeutics headquartered?
Simmunext Biotherapeutics is headquartered in Nijmegen, Netherlands.
-
What is the size of Simmunext Biotherapeutics?
Simmunext Biotherapeutics has 3 total employees.
-
What industry is Simmunext Biotherapeutics in?
Simmunext Biotherapeutics’s primary industry is Biotechnology.
-
Is Simmunext Biotherapeutics a private or public company?
Simmunext Biotherapeutics is a Private company.
-
What is Simmunext Biotherapeutics’s current revenue?
The current revenue for Simmunext Biotherapeutics is .
-
Who are Simmunext Biotherapeutics’s investors?
VFF Gelderland, Oncode Oncology Bridge Fund, Radboud University, and Radboud university medical center have invested in Simmunext Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process